Obesity
Not recruitingEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
- Disease:Obesity
- Substances:–
Bulgaria- Participants:18–64 years · 65+ years
- Sponsor:Metsera Inc.
Rare diseases
Investigational molecules
Locations
Back to Bulgaria66 clinical trials in Gabrovo, Bulgaria across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
Bulgaria
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on advanced cancer treatments, including studies for breast cancer, prostate cancer, lung cancer, and bladder cancer. Research encompasses both targeted therapies and combination treatments.
Special emphasis on developing targeted therapies for specific genetic mutations and combinations with immunotherapy.
Comprehensive research into respiratory conditions, with particular focus on chronic diseases and their management through innovative therapeutic approaches.
Trials evaluate both single and combination therapies for improving lung function and quality of life.
Advanced research in chronic skin conditions, investigating new therapeutic options for various dermatological disorders.
Focus on developing both topical and systemic treatments for moderate to severe cases.
Innovative studies addressing heart conditions and related metabolic disorders, including new approaches to managing cholesterol and heart failure.
Emphasis on both preserved and reduced ejection fraction heart failure treatments.
Research focusing on viral infections and preventive medicine, including vaccine development and infection management.
Special attention to vaccine safety and efficacy in various age groups.
Tell us about your condition – we search every trial in Europe and connect you with the right site.